Displaying 21 to 32 of 32 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Point Biomedical Inc Developer of a microsphere that freely circulates when injected into the bloodstream. |
United States | 1 Jan 2008 | Series E |
|
|
|
Principia Biopharma Discoverer and developer of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. |
United States | 1 Oct 2012 | Series A |
|
|
|
Rib-X Pharmaceuticals Inc |
United States | N/A |
||
|
|
Santarus Inc Drug company focused on gastrointestinal diseases and disorders. |
United States | N/A |
||
|
|
Scion Pharmaceuticals Inc |
United States | N/A |
||
|
|
Scynexis Inc Provider of drug discovery, development, and manufacturing projects. |
United States | N/A |
||
|
|
Semprus BioSciences Develops implantable and permanently-antimicrobial surface technology that is incorporated into medical devices |
United States | 1 Dec 2010 | Series B |
|
|
|
Sequenom Inc Biotechnology tools and diagnostics company. |
United States | N/A |
||
|
|
SpringLeaf Therapeutics Inc Develops and manufactures a drug delivery system called the "patch pump" to deliver drugs subcutaneously. |
United States | N/A |
||
|
|
Thrasos Therapeutics |
N/A Active |
|||
|
|
Torrey Pines Therapeutics Inc |
United States | N/A |
||
|
|
Trinity Biosystems Inc Developer of a platform for the delivery of peptides across intact mucosal surfaces. |
United States | N/A Active |